Piperacillin, Tazobactam
- Product NDC
- 25021-181
- 11-digit product format
- 250210181
- Labeler code
- 25021
- Product ID
- 25021-181_a6724256-14c5-4408-83a5-a964f146f0d5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Piperacillin Sodium, Tazobactam Sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Sagent Pharmaceuticals
- Application
- ANDA208675
- Marketing category
- ANDA
- Marketing start
- 2021-02-28
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 36; 4.5 g/152mL; g/152mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC], Penicillins [CS], beta Lactamase Inhibitor [EPC], beta Lactamase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208675-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A208675-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 4b0b4de00fa7… | |
| 2022-03-09 01:35 UTC | 2022-03 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 87673890dc5c… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208675-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2021-02-16 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A208675-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A208675-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208675-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A208675-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208675-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208675-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208675-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208675-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208675-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208675-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A208675-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208675-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208675-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208675-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A208675-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208675-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A208675-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A208675-001 | AP | 1 | 4b0b4de00fa7… |
| 2022-03-09 01:35 UTC | 2022-03 | A208675-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A208675-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208675-001 | AP | 1 | 87673890dc5c… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208675-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A208675-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A208675-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208675-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208675-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208675-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208675-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A208675-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A208675-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208675-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A208675-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A208675-001 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A208675-001 | AP | 1 | cb3db0bc1861… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A208675-001 | AP | 1 | a50c72e98297… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Piperacillin, Tazobactam
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PIPERACILLIN SODIUM | 36 g/152mL |
| TAZOBACTAM SODIUM | 4.5 g/152mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| M98T69Q7HP | Internal UNII lookup |
| UXA545ABTT | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312447 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 83f4adcd-893c-4e9e-8f2b-e06299dcf34d | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 5fa255cf-091e-4504-8ebf-eef4259776e8 | Product name | 1 | 20260112 |
| a6bfe911-d09e-4049-bcde-a3213184a72c | Product name | 8 | 20240501 |
| 61877847-a958-4874-a7cf-2bbeff51a37b | Product name | 2 | 20180717 |
| e0d9b1cf-1fe5-42a8-b30f-70b3a7bd8d22 | Product name | 1 | 20150316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 25021-181-99 | Piperacillin, Tazobactam | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 14 | |
| 25021-181-99 | Piperacillin, Tazobactam | 152 mL in 1 BOTTLE | INJECTION, POWDER, LYOPHILIZED, | 152 | 14 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 25021-181-99 | EA - Each | 25021-181 | ac169699-2bc9-44e4-8ac3-3e023f4cbbac | 1 | 2021-05-05 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 25021-181 | PIPERACILLIN, TAZOBACTAM (PIPERACILLIN SODIUM, TAZOBACTAM SODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 14 | Current NDC, Legacy NDC, 2 package rows | 20241120_83f4adcd-893c-4e9e-8f2b-e06299dcf34d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Piperacillin, Tazobactam | PIPERACILLIN SODIUM, TAZOBACTAM SODIUM | Sagent Pharmaceuticals | 83f4adcd-893c-4e9e-8f2b-e06299dcf34d | 2024-08-31 | Warnings, Adverse reactions | 208675 ANDA208675 25021-181 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312447 | piperacillin 200 MG/ML / tazobactam 25 MG/ML Injectable Solution | PSN | 83f4adcd-893c-4e9e-8f2b-e06299dcf34d | 14 |
| 312447 | piperacillin 200 MG/ML / tazobactam 25 MG/ML Injectable Solution | SCD | 83f4adcd-893c-4e9e-8f2b-e06299dcf34d | 14 |
| 312447 | piperacillin (as piperacillin sodium) 200 MG/ML / tazobactam (as tazobactam sodium) 25 MG/ML Injectable Solution | SY | 83f4adcd-893c-4e9e-8f2b-e06299dcf34d | 14 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 25021-181-99 | 25021018199 | 1 BOTTLE in 1 CARTON (25021-181-99) / 152 mL in 1 BOTTLE | 1 bottle | 2021-02-28 | 0000-00-00 | No | No | Current |